25 Einträge gefunden

1. Return of individual genomic research results within the PRAEGNANT multicenter registry study

   1. Huebner, Hanna
   2. Ruebner, Matthias
   3. Kurbacher, Christian
   4. Hadji, Peyman
   5. Hartkopf, Andreas D
   6. Lux, Michael P
   7. Huober, Jens

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

   1. Engler, Tobias
   2. Fasching, Peter A
   3. Lüftner, Diana
   4. Hartkopf, Andreas D
   5. Müller, Volkmar
   6. Kolberg, Hans-Christian
   7. Hadji, Peyman

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer

   1. Lüftner, Diana
   2. Hartkopf, Andreas D
   3. Lux, Michael P
   4. Overkamp, Friedrich
   5. Tesch, Hans
   6. Titzmann, Adriana
   7. Pöschke, Patrik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and Biomarkers

   1. Ditsch, Nina
   2. Stickeler, Elmar
   3. Behrens, Annika
   4. Belleville, Erik
   5. Fasching, Peter A
   6. Fehm, Tanja N
   7. Hartkopf, Andreas D

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
7. Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients

   1. Lux, Michael P
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Janni, Wolfgang
   6. Belleville, Erik
   7. Stickeler, Elmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis

   1. Hartkopf, Andreas D
   2. Brucker, Sara Y
   3. Taran, Florin-Andrei
   4. Harbeck, Nadia
   5. von Au, Alexandra
   6. Naume, Bjørn
   7. Pierga, Jean-Yves

   2021 - Forschungsinformationssystem des UKE
9. Update Breast Cancer 2021 Part 1 - Prevention and Early Stages

   1. Stickeler, Elmar
   2. Aktas, Bahriye
   3. Behrens, Annika
   4. Belleville, Erik
   5. Ditsch, Nina
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
10. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

    1. Schneeweiss, Andreas
    2. Ettl, Johannes
    3. Lüftner, Diana
    4. Beckmann, Matthias W
    5. Belleville, Erik
    6. Fasching, Peter A
    7. Fehm, Tanja N

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
11. HER2-targeted therapy influences CTC status in metastatic breast cancer

    1. Deutsch, Thomas M
    2. Riethdorf, Sabine
    3. Fremd, Carlo
    4. Feisst, Manuel
    5. Nees, Juliane
    6. Fischer, Chiara
    7. Hartkopf, Andreas D

    2020 - Forschungsinformationssystem des UKE
12. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

    1. Schneeweiss, Andreas
    2. Ettl, Johannes
    3. Lüftner, Diana
    4. Beckmann, Matthias W
    5. Belleville, Erik
    6. Fasching, Peter A
    7. Fehm, Tanja N

    2020 - Forschungsinformationssystem des UKE
13. Update Breast Cancer 2020 Part 1 - Early Breast Cancer:Consolidation of Knowledge About Known Therapies

    1. Schneeweiss, Andreas
    2. Hartkopf, Andreas D
    3. Müller, Volkmar
    4. Wöckel, Achim
    5. Lux, Michael P
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
14. Update Breast Cancer 2020 Part 3 - Early Breast Cancer

    1. Huober, Jens
    2. Schneeweiss, Andreas
    3. Hartkopf, Andreas D
    4. Müller, Volkmar
    5. Lux, Michael P
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
15. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

    1. Michel, Laura L
    2. Hartkopf, Andreas D
    3. Fasching, Peter A
    4. Kolberg, Hans-Christian
    5. Hadji, Peyman
    6. Tesch, Hans
    7. Häberle, Lothar

    2020 - Forschungsinformationssystem des UKE
16. Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

    1. Huebner, Hanna
    2. Kurbacher, Christian M
    3. Kuesters, Geoffrey
    4. Hartkopf, Andreas D
    5. Lux, Michael P
    6. Huober, Jens
    7. Volz, Bernhard

    2020 - Forschungsinformationssystem des UKE
17. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer:New Treatments and Implementation of Therapies with Companion Diagnostics

    1. Lüftner, Diana
    2. Schneeweiss, Andreas
    3. Hartkopf, Andreas D
    4. Müller, Volkmar
    5. Wöckel, Achim
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
18. Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

    1. Fasching, Peter A
    2. Hartkopf, Andreas D
    3. Gass, Paul
    4. Häberle, Lothar
    5. Akpolat-Basci, Leyla
    6. Hein, Alexander
    7. Volz, Bernhard

    2019 - Forschungsinformationssystem des UKE
19. Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers

    1. Taran, Florin-Andrei
    2. Schneeweiss, Andreas
    3. Lux, Michael P
    4. Janni, Wolfgang
    5. Hartkopf, Andreas D
    6. Nabieva, Naiba
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
20. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

    1. Schneeweiss, Andreas
    2. Lux, Michael P
    3. Janni, Wolfgang
    4. Hartkopf, Andreas D
    5. Nabieva, Naiba
    6. Taran, Florin-Andrei
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE